Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 491-497, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cremonesi, L.
Right arrow Articles by Arosio, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cremonesi, L.
Right arrow Articles by Arosio, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2001;47:491-497.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Double-Gradient Denaturing Gradient Gel Electrophoresis Assay for Identification of L-Ferritin Iron-responsive Element Mutations Responsible for Hereditary Hyperferritinemia-Cataract Syndrome: Identification of the New Mutation C14G

Laura Cremonesi1, Antonella Fumagalli1, Nadia Soriani1, Maurizio Ferrari1, Sonia Levi2, Silvana Belloli3, Giuseppina Ruggeri3 and Paolo Arosio2,3,a

1 Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) H. San Raffaele, Unit of Genetics and Molecular Diagnostics and
2 Unit of Protein Engineering, Via Olgettina 58, 20132 Milan, Italy.

3 Section of Chemistry, Faculty of Medicine, University of Brescia, 25100 Brescia, Italy.
a Address correspondence to this author at: Unit of Protein Engineering, Dibit, HSR, Via Olgettina 58, 20132 Milan, Italy. Fax 39-02-2643 4844; e-mail p.arosio{at}hsr.it.

Background: Hereditary hyperferritinemia-cataract syndrome is an autosomic dominant disorder caused by heterogeneous mutations on the iron-responsive element (IRE) of ferritin L-chain mRNA. The mutations described to date were identified by direct sequencing of DNA from probands with hyperferritinemia often associated to bilateral cataracts. A direct genetic approach on a large population is useful to recognize polymorphisms in the DNA region and the prevalence of mutations associated with minor increases in serum ferritin and subclinical cataracts. We developed a rapid DNA scanning technique to detect mutations in a single electrophoretic analysis.

Methods: The double-gradient denaturing gradient gel electrophoresis (DG-DGGE) method consisted of PCR amplification of the target genomic DNA with GC-clamped oligonucleotides. The sequence encoded the 5' untranslated flanking region of ferritin L-chain mRNA, which includes an IRE stem-loop structure. The product was subjected to DG-DGGE (8.5–15% polyacrylamide and 50–95% denaturant) to separate the homo- and heteroduplexes.

Results: The method clearly identified all eight accessible mutations, including C-G transversions, which are the most difficult to detect. The method was applied to scan DNA samples from 50 healthy subjects and from 230 subjects with serum ferritin >400 µg/L. The new mutation G14C was identified.

Conclusions: The DG-DGGE method detects all the mutations in the L-ferritin IRE sequence, is rapid and economical, and can be applied to scan large populations. The first population study indicated that the mutations are rare and may involve regions of the IRE structure not yet characterized.




The following articles in journals at HighWire Press have cited this article:


Home page
Arch OphthalmolHome page
J. E. Craig, J. B. Clark, J. L. McLeod, M. A. Kirkland, G. Grant, J. E. Elder, M. G. Toohey, L. Kowal, H. F. Savoia, C. Chen, et al.
Hereditary Hyperferritinemia-Cataract Syndrome: Prevalence, Lens Morphology, Spectrum of Mutations, and Clinical Presentations
Arch Ophthalmol, December 1, 2003; 121(12): 1753 - 1761.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. M. Torti and S. V. Torti
Regulation of ferritin genes and protein
Blood, May 15, 2002; 99(10): 3505 - 3516.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.